Abstract
The MC-38 C57BL/6 mouse colon adenocarcinoma cell line has been transduced with a retroviral construct containing cDNA encoding the human carcinoembryonic antigen (CEA) gene [Robbins PF, Kantor JA, Salgaller M, Horan Hand P, Fernsten PD, Schlom J (1991) Cancer Res 51: 3657]. Two clones, MC-38-ceal and MC-38-cea2, expressed high levels of CEA on their cell surface. A third CEA-expressing cell line, MCA-102-cea3, was similarly derived by transduction of the MCA-102 C57BL/6 mouse fibrosarcoma cell line and is described here. In this study, the three CEA-transduced murine tumor cell lines (MC-38-cea1, MC-38-cea2, MCA-102-cea3) were evaluated for their tumorigenic potential, as well as their ability to serve as in vivo model systems for active and passive immunotherapy studies. Parameters that were investigated include tumor growth rate, the antibody response of the host to CEA, and the CEA content of the tumors. The MC-38-cea2 model appeared to be the most appropriate for immunotherapy studies. Biodistribution studies, using an125I-labeled anti-CEA mAb, demonstrated efficient tumor targeting of MC-38-cea2 tumors in C57BL/6 and athymic mice.
Similar content being viewed by others
References
Barnett TR, Kretschmer A, Austen DA, Goebel SJ (1989) Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family. J Cell Biol 108: 267
Bast RC Jr, Feeney M, Lazarus H, et al (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68: 1331
Beauchemin N, Benchimol S, Cournoyer D, Fuks A, Stanners CP (1987) Isolation and characterization of full-length functional cDNA clones for human carcinoembryonic antigen. Mol Cell Biol 7: 3221
Benchimol S, Fuks A, Jothy S, Beachemin N, Shirota K, Stanners CP (1989) Carcinoembryonic antigen, a human tumor marker, functions as an intracellular adhesion molecule. Cell 57: 327
Colcher D, Zalutsky M, Kaplan W, Kufe D, Austin F, Schlom J (1983) Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody. Cancer Res 43: 736
Colcher D, Milenic D, Roselli M, Raubitschek A, Yarranton G, King D, Adair J, Whittle N, Bodmer M, Schlom J (1989) Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3. Cancer Res 49: 1738
Estin CD, Stevenson US, Plowman GD, Hu S-L, Sridhar P, Hellstrom I, Brown JP, Hellstrom KE (1988) Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy. Proc Natl Acad Sci USA 85: 1052
Fox BA, Spiess PF, Kasid A, Puri R, Mule JJ, Weber JS, Rosenberg SA (1990) In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. J Biol Response Mod 9: 499
Gold P, Freedman SO (1965) Specific carcinoembryonic antigens of the human digestive system. J Exp Med 122: 467
Guadagni F, Witt PL, Robbins PF, Schlom J, Greiner JW (1990) Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma. Cancer Res 50: 6248
Guesdon JL, Terynck T, Avrameas S (1979) The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27: 1131
Hostetter RB, Augustus LB, Mankarious R, Chi K, Fan D, Toth C, Thomas P, Jessup JM (1990) Carcinoembryonic antigen as a selective enhancer of colorectal cancer metastasis. J Natl Cancer Inst 82: 380
Johnson VG, Schlom J, Paterson AJ, Bennett J, Magnani JL, Colcher D (1986) Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res 46: 850
Kantor J, Irvine K, Abrams S, Kaufmann H, DiPietro J, Schlom J (1992) Anti-tumor activity and immune responses induced by a recombinant vaccinia-carcinoembryonic antigen (CEA) vaccine. J Natl Cancer Inst 84: 1084
Kaufman H, Schlom J, Kantor J (1991) A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA). Int J Cancer 48: 900
Koprowski H, Steplewski Z, Mitchell K, Herlyn M (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 5: 957
Kufe D, Inghirami G, Abe M, Hayes D (1984) Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3: 223
Lafreniere R, Rosenberg SA (1986) A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J Natl Cancer Inst 76: 309
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265
Mann R, Mulligan RC, Baltimore D (1983) Construction of a retrovirus packaging mutant and its use to produce a helper-free defective retrovirus. Cell 33: 153
Muraro R, Wunderlich D, Thor A, Lundy J, Noguchi P, Cunningham R, Schlom J (1985) Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res 45: 5769
Noguchi P, Wallace R, Johnson J, Early E, O'Brien S, Ferrone S, Pellegrino MA, Milstein J, Needy C, Browne W, Petricciani J (1979) Characterization of WiDr: a human colon carcinoma cell line. In Vitro (Rockville) 15: 401
Oikawa S, Nakazato H, Kosaki G (1987) Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequences. Biochem Biophys Res Commun 42: 511
Primus FJ, Kelley EA, Hansen HJ, Goldenberg DM (1988) “Sandwich”-type immunoassay of carcinoembryonic antigen in patients receiving murine antibodies for diagnosis and therapy. Clin Chem 34: 261
Robbins PF, Kantor JA, Salgaller M, Horan Hand P, Fernsten PD, Schlom J (1991) Transduction and expression of the human carcinoembryonic antigen (CEA) gene in a murine colon carcinoma cell line. Cancer Res 51: 3657
Rose TM, Plowman GD, Teplow DB, Dreyer WJ, Hellstrom KE, Brown JP (1986) Primary structure of human melanoma-associated antigen p97 (melanotranferrin) deduced from the mRNA sequence. Proc Natl Acad Sci USA 83: 1261
Schlom J (1986) Basic principle and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 46: 3225
Thor A, Ohuchi N, Szpak CA, Johnston WW, Schlom J (1986) Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res 46: 3118
Tom BH, Rutzky LH, Jakstys MM, Oyasu R, Kaye CI, Kahan BD (1976) Human colonic adenocarcinoma cells: I. Establishment and description of a new cell line. In Vitro (Rockville) 12: 180
von Kleist S, Burtin P (1979) Antigens cross-reacting with CEA. In: Herberman RB, McIntire KR (eds). Immunodiagnosis of cancer, vol 9 Dekker, New York, p 322
Wreschner DH, Hareuveni M, Tsarfaty I, Smorodinsky N, Horev J, Zaretsky J, Kotes P, Weiss M, Lathe R, Dion A, Keydar I (1990) Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur J Biochem 189: 463
Zimmermann W, Weber B, Ortleib B, Rudert F (1988) Chromosomal localization of the carcinoembryonic antigen gene family and differential expression in various tumors. Cancer Res 48: 2550
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hand, P.H., Robbins, P.F., Salgaller, M.L. et al. Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies. Cancer Immunol Immunother 36, 65–75 (1993). https://doi.org/10.1007/BF01754404
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01754404